Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

592
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
592

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessment of aortic insufficiency during Impella support as a bridge to durable left ventricular assist device implantation and its long-term progression.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs·2026
Same author

Left Ventricular Venting during On-Pump Beating-Heart Coronary Artery Bypass Grafting for Advanced Ischemic Cardiomyopathy: A Surgical Strategy to Achieve Complete Revascularization.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·2026
Same author

Door-to-unload time and mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Mediastinal Chyloma after Ascending Aortic Replacement: A Case of Delayed, Localized Chyle Leakage.

Annals of vascular diseases·2026
Same author

Successful Sealing of Steam Pop-Related Left Ventricular Summit Perforation With Partial Impella Support.

JACC. Case reports·2026
Same author

Impact of Frailty on Mortality and Adverse Events After Durable Left Ventricular Assist Device Implantation: Insights From the J-MACS Registry.

Journal of cardiac failure·2026
Same journal

[Secondary Pneumothorax due to Rupture of Pulmonary Rheumatoid Nodule:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Thoracoscopic Right Upper Lobectomy for Lung Cancer with Tracheal Bronchus:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Neoplastic Cardiac Tamponade Manifesting as Left Ventricular Diastolic Dysfunction:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Non-anastomotic Pseudoaneurysm due to Sternal Wire Removal After Ascending Aorta Grafting:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Successful Staged Total Aortic Replacement in a Young Patient with Marfan Syndrome:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same journal

[Massive Left Ventricular Thrombus Following Steroid Therapy for Immunoglobulin( Ig) G4-related Ophthalmic Disease:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
查看所有相关文章

相关实验视频

Updated: Jan 16, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K

[可植入的左心室辅助装置]

Masato Mutsuga1

  • 1Department of Cardiac Surgery, Nagoya University, Nagoya, Japan.

Kyobu geka. The Japanese journal of thoracic surgery
|September 25, 2025
PubMed
概括
此摘要是机器生成的。

左心室辅助装置 (LVAD) 在其他治疗方法失败时,为严重的心力衰竭提供了至关重要的支持. 在LVAD技术的进步正在改善患者的治疗结果和生活质量,扩大治疗选择.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.1K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K

相关实验视频

Last Updated: Jan 16, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.1K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K

科学领域:

  • 心脏病学 心脏病学
  • 生物医学工程 生物医学工程

背景情况:

  • 严重的心力衰竭显著影响预后和生活质量.
  • 对于耐药病例来说,传统的治疗方法往往是不够的.
  • 心脏移植受限于供体的可用性和资格标准.

研究的目的:

  • 审查左心室辅助装置 (LVAD) 在治疗严重心力衰竭中的作用和进展.
  • 讨论LVAD的扩展应用,包括目的地治疗 (DT).
  • 突出技术创新,改善LVAD疗效和患者的治疗结果.

主要方法:

  • 关于心室辅助器件 (VAD) 技术和临床应用的当前文献的综述.
  • 对LVAD使用趋势的分析,包括日本目的地治疗的扩张.
  • 检查LVAD设计和功能的技术进步.

主要成果:

  • LVAD 作为移植 (BTT) 或目的地治疗 (DT) 的关键桥梁.
  • 对于LVAD的目的地治疗正在扩大,保险覆盖率和设施可用性增加.
  • 技术进步包括小型化,连续流量 (轴向,离心) 和改进的生物相容性.
  • 像BiVACOR全人工心脏这样的新兴技术显示出未来应用的前景.

结论:

  • LVAD是晚期心力衰竭的关键治疗选择,改善了存活率和生活质量.
  • 持续的技术创新正在提高LVAD的可行性,效率和长期成果.
  • 目的地治疗的扩大扩大了对更广泛的患者群体的先进心脏支持的访问.